Granisetron

格拉司琼

Report date: 2026/05/11 20:01:57

Base Information

Drug NameGranisetron
Drug Alias Name格兰西龙GranisetronumSancusoSustol善可舒 +[6] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSerotonin 3 (5-HT3) receptor antagonists
TargetsSerotonin 3 (5-HT3) receptor
Therapy Area/IndicationsChemotherapy-induced nausea and vomitingSolid tumoursVomiting +[8] 
Global Approved IndicationsChemotherapy-induced nausea and vomitingVomitingNausea +[4] 
Approved Indications in ChinaVomitingNauseaPostoperative Nausea and Vomiting
Original Approved Country/TerritoryMainland China
Original Approved Date1997/01/01
Country/TerritoryUnited StatesItalyEgypt +[6] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesKyowa Hakko Kirin Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesKyowa Kirin IncLee’S Pharmaceutical Holdings LtdAcino Pharma Gmbh +[7] 
Inactive CompaniesFudan UniversityStrakan International LtdKyowa Kirin Pharmaceutical Development Ltd +[8] 
Active IndicationsChemotherapy-induced nausea and vomitingVomitingNausea +[5] 
Inactive IndicationsSolid tumoursGastroparesisNeoplasms

Other Information

ATC CodeA04AA02
Related LinksWikipediaDrugBankKEGG